- Home
- SLNO vs INTR Comparison
SLNO vs INTR Comparison
Compare SLNO & INTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLNO
- INTR
- Stock Information
- Founded
- SLNO 1999
- INTR 1994
- Country
- SLNO United States
- INTR Brazil
- Employees
- SLNO N/A
- INTR N/A
- Industry
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- INTR
- Sector
- SLNO Health Care
- INTR
- Exchange
- SLNO Nasdaq
- INTR Nasdaq
- Market Cap
- SLNO 3.8B
- INTR 3.3B
- IPO Year
- SLNO 2014
- INTR N/A
- Fundamental
- Price
- SLNO $68.57
- INTR $8.08
- Analyst Decision
- SLNO Strong Buy
- INTR Hold
- Analyst Count
- SLNO 10
- INTR 2
- Target Price
- SLNO $112.50
- INTR $5.55
- AVG Volume (30 Days)
- SLNO 1.6M
- INTR 2.9M
- Earning Date
- SLNO 08-06-2025
- INTR 08-06-2025
- Dividend Yield
- SLNO N/A
- INTR 0.37%
- EPS Growth
- SLNO N/A
- INTR 69.31
- EPS
- SLNO N/A
- INTR 0.47
- Revenue
- SLNO $32,656,999.00
- INTR $974,787,476.00
- Revenue This Year
- SLNO N/A
- INTR $80.30
- Revenue Next Year
- SLNO $209.31
- INTR $19.81
- P/E Ratio
- SLNO N/A
- INTR $17.37
- Revenue Growth
- SLNO N/A
- INTR 38.56
- 52 Week Low
- SLNO $41.50
- INTR $3.88
- 52 Week High
- SLNO $90.32
- INTR $8.37
- Technical
- Relative Strength Index (RSI)
- SLNO 32.58
- INTR 62.43
- Support Level
- SLNO $66.72
- INTR $7.47
- Resistance Level
- SLNO $87.17
- INTR $8.37
- Average True Range (ATR)
- SLNO 3.81
- INTR 0.28
- MACD
- SLNO -1.52
- INTR 0.03
- Stochastic Oscillator
- SLNO 21.55
- INTR 85.27
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.
About INTR Inter & Co. Inc.
Inter & Co Inc operates as a digital bank. The company's segment includes Banking & Spending; Investments; Insurance Brokerage; and Inter Shop. It generates maximum revenue from the Banking & Spending segment which comprises a wide range of banking products and services, such as checking accounts, cards, deposits, loans and advances, and other services, which are available to the clients by means of Inter's mobile application.